Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 28: 100-104, 1982;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Szabo, G. K.
Right arrow Articles by Browne, T. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Szabo, G. K.
Right arrow Articles by Browne, T. R.

Clinical Chemistry, Vol 28, 100-104, Copyright © 1982 by American Association for Clinical Chemistry

Improved isocratic liquid-chromatographic simultaneous measurement of phenytoin, phenobarbital, primidone, carbamazepine, ethosuximide, and N- desmethylmethsuximide in serum

GK Szabo and TR Browne

We describe an improved "high-pressure" liquid-chromatographic assay for simultaneous determination in serum of the five major antiepileptic drugs (ethosuximide, primidone, phenobarbital, phenytoin, and carbamazepine) and N-desmethylmethsuximide (the compound that must be quantitated for therapeutic drug monitoring of the antiepileptic drug methsuximide). Serum protein is precipitated with an acetone solution containing 5-ethyl-5-(p-methylphenyl)barbituric acid as the internal standard. The centrifuged supernate is injected onto the chromatographic column. Drugs and internal standard are eluted at 30 degrees C with mobile phase containing acetonitrile/methanol/phosphate buffer (17/28/55 by vol) at a flow rate of 0.7 mL/min, monitored at 195 nm. Analysis time is about 20 min. Quantitation is by measurement of peak areas. Analytical and absolute recoveries varied from 95 to 104%. Within-day coefficients of variation ranged from 1.6 to 5.4%, between- day CVs from 0.0 to 3.4% in subtherapeutic, therapeutic, and toxic samples. Resolution of therapeutic concentrations of all six drugs was complete. As yet, we have found no drug or drug metabolite that interferes.


The following articles in journals at HighWire Press have cited this article:


Home page
 J. Nutr.Home page
S. C. Rathman, J. F. Gregory III, and R. J. McMahon
Pharmacological Biotin Supplementation Maintains Biotin Status and Function in Rats Administered Dietary Carbamazepine
J. Nutr., September 1, 2003; 133(9): 2857 - 2862.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
S. C. Rathman, R. K. Blanchard, L. Badinga, J. F. Gregory III, S. Eisenschenk, and R. J. McMahon
Dietary Carbamazepine Administration Decreases Liver Pyruvate Carboxylase Activity and Biotinylation by Decreasing Protein and mRNA Expression in Rats
J. Nutr., July 1, 2003; 133(7): 2119 - 2124.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
S. C. Rathman, S. Eisenschenk, and R. J. McMahon
The Abundance and Function of Biotin-Dependent Enzymes Are Reduced in Rats Chronically Administered Carbamazepine
J. Nutr., November 1, 2002; 132(11): 3405 - 3410.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1982 by the American Association for Clinical Chemistry.